carrier status test

Two years after FDA letter, 23andMe finally relaunches consumer genetic testing in US
By Aditi Pai | 12:23 pm | October 22, 2015
Almost two years after the FDA first told 23andMe to halt sales on its mail-order direct-to-consumer genetic testing service for disease risks, the company has relaunched a version of its new Personal Genome Service (PGS), which now meets FDA standards.